Back to News
Oct 24, 2025 12:00 PM

What to Expect from Biomarin Pharmaceutical's Earnings

Biomarin Pharmaceutical (NASDAQ:BMRN) is preparing to release its quarterly earnings on Monday, 2025-10-27. Here's a brief overview of what investors should keep in mind before the announcement.

Analysts expect Biomarin Pharmaceutical to report an earnings per share (EPS) of $0.53.

Anticipation surrounds Biomarin Pharmaceutical's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.

New investors should understand that while earnings performance is important, market reactions are often driven by guidance.

Historical Earnings Performance

Last quarter the company beat EPS by $0.51, which was followed by a 2.69% increase in the share price the next day.

Here's a look at Biomarin Pharmaceutical's past performance and the resulting price change:

Quarter

Q2 2025

Q1 2025

Q4 2024

Q3 2024

EPS Estimate

0.93

0.71

0.74

0.52

EPS Actual

1.44

1.13

0.92

0.91

Price Change %

3.00

-1.00

5.00

-5.00

Biomarin Pharmaceutical Share Price Analysis

Shares of Biomarin Pharmaceutical were trading at $54.55 as of October 23. Over the last 52-week period, shares are down 22.15%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

Insights Shared by Analysts on Biomarin Pharmaceutical

For investors, grasping market sentiments and expectations in the industry is vital. This analysis explores the latest insights regarding Biomarin Pharmaceutical.

Analysts have given Biomarin Pharmaceutical a total of 4 ratings, with the consensus rating ...